NDC 54868-5494-2 - Lyrica
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-5494
- Requested NDC
- 54868-5494-2
- Package NDCs from labels
- 54868-5494-0, 54868-5494-1, 54868-5494-2
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2014-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lyrica - Physicians Total Care, Inc. | Physicians Total Care, Inc. | 2014-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-5494-0 | Lyrica | 90 in 1 BOTTLE | CAPSULE | 90 | 4 | |
| 54868-5494-1 | Lyrica | 30 in 1 BOTTLE | CAPSULE | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-5494 | LYRICA (PREGABALIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 4 | 2 package rows | 20140218_3e1fb774-7460-44d2-bf96-a17c59999676.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-5494-0 | EA - Each | 54868-5494 | 54535615-43df-47a6-a5b8-754dcacc9159 | 1 | 2012-07-24 |
| 54868-5494-1 | EA - Each | 54868-5494 | c3b56869-e6a5-4fd3-b73d-7a0b42e8d5a1 | 1 | 2012-07-24 |
| 54868-5494-2 | EA - Each | 54868-5494 | 5be84935-0f65-4145-b6db-8d1ca7619cb5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3f002a7f-e632-e58f-e063-6394a90abce8 | 2025-09-17 | Warnings, Adverse reactions | 55JG375S6M |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3f00c179-336d-e534-e063-6294a90a9141 | 2025-09-17 | Warnings, Adverse reactions | 483446 55JG375S6M |
| CVS SPF 50 Face Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | CVS | 26a69a47-947a-a478-e063-6394a90aa468 | 2025-09-16 | Warnings | 15FIX9V2JP |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 8ac0689e-47a3-44d7-bf98-a919c302726d | 2025-09-15 | Warnings, Adverse reactions | 483446 55JG375S6M |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals Inc. | dc50f01d-1802-4666-8f2f-35980a40990f | 2025-09-15 | Warnings, Adverse reactions | 483440 55JG375S6M |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 25345672-1368-4e3a-95b2-ca45fe120294 | 2025-09-12 | Warnings, Adverse reactions | 483440 55JG375S6M |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 3e9cfeb9-1e2b-ea79-e063-6394a90a67b1 | 2025-09-12 | Warnings, Adverse reactions | 55JG375S6M |
| Owell Naturals Draw Salve, Arnica, Silicea | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1c9dab31-de1f-911b-e063-6294a90a0391 | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Owell Naturals Draw Salve | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1536ff1e-16b8-fbbc-e063-6394a90a628e | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals Inc. | e8e272a4-c181-4573-822b-2bb315b6ad37 | 2025-09-12 | Warnings, Adverse reactions | 483438 55JG375S6M |
| PREGABALIN | PREGABALIN | Cadila Pharmaceuticals Limited | 170c0c95-2ee8-4dff-bbd6-b87a21e8cf81 | 2025-09-12 | Warnings, Adverse reactions | 483440 483442 483448 483438 483450 483446 55JG375S6M |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | ceedde96-fdaf-4708-9ca1-e48e052cde75 | 2025-09-12 | Warnings, Adverse reactions | 483438 55JG375S6M |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals Inc. | a0da0534-b386-4c93-ae89-03b0e3325e02 | 2025-09-11 | Warnings, Adverse reactions | 483450 55JG375S6M |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 1760ccdc-46f7-4182-a563-96b13212cb7e | 2025-09-11 | Warnings, Adverse reactions | 483450 55JG375S6M |
| sunscreen | TITANIUM DIOXIDE(NANO) | Mingyu (guangdong) Cosmetics Technology Co., Ltd | 3e6fe9f3-486b-bba7-e063-6294a90adf37 | 2025-09-10 | Warnings | 15FIX9V2JP |
| Pregabalin | PREGABALIN | Preferred Pharmaceuticals, Inc. | 3dbfd868-8408-4514-ba1c-04a5d095c16a | 2025-09-10 | Warnings, Adverse reactions | 483448 55JG375S6M |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | ETJ7Z6XBU4 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | ETJ7Z6XBU4 |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 31e7caf6-0a8b-f343-e063-6294a90ad729 | 2025-09-08 | Warnings, Adverse reactions | 483438 55JG375S6M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.